AEON vs KEYS · P/E 0.0, $8.6M cap vs P/E 57, rev $4.98B
AEON Biopharma, Inc. (AEON) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
AEON does not have a complete income-statement cache yet.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the AEON and KEYS stock pages for the full models.
Not investment advice.